PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Opioid Litigation: Evading the Widening Crosshairs

Advancing Organizational Goals with AI-Supported Smart Searching

The Rise of China Biopharma

Advertisement
Viewpoint
Does the Pfizer Restructuring Make Sense?
The Pfizer restructuring will be a case study in whether corporate restructuring & innovation can co-exist or whether M&A is the more viable answer, writes Edward Pratesi
/Read more/
Advertisement
The world is larger than you think - Don't get lost
Cultural insight the key to doing business in a globalized world. Become a global business insider with Pharma Reports, a series of PDF-format reports detailing the latest market conditions and opportunities in more than 10 countries.
Explore now
Global
European Drug Innovators Face Tough Fight to Maintain Research Incentives
Research-based companies in Europe look as though they have lost one battle on preserving incentives for innovation – but the bigger war is only now getting underway, writes Reflector
/Read more/
Advertisement
Don't let your campaign fall apart
Strategic product management is the glue holding an operation together. This Pharmaceutical Executive handbook is your go-to guide for effective and profitable product management.
Read more
Organizational Effectiveness
The Key to Better Navigating VUCA Industry Conditions
Alison Horstmeyer discusses how pharma executives can apply four attributes of curiosity to negotiate VUCA (volatile, uncertain, complex, and ambiguous) conditions and improve organizational outcomes
/Read more/
Advertisement
A Framework for Successful Biopharma Launches Understanding the launch archetype and identifying critical success factors
On Demand
Learn more
Calendar
/ August 14–15: Publication Planning 2018 /
Philadelphia, PA
/ August 15–16: Reimbursement and Access 2018 /
Philadelphia, PA
/ August 20–22: Transparency and Aggregate Spend 2018 /
Washington, DA, PA
/ September 25–26: Finance and Accounting for Bioscience Companies /
Boston, MA
/ September 25–26: 4th Annual Bio/Pharmaceutical Product Launch Summit /
Cambridge, MA
/ September 27: 3rd Edition Drug Pricing Transparency Congress /
Philadelphia, PA
/ October 2–3: Advanced Therapies Commercialization Congress /
Amsterdam, The Netherlands
/ November 13–14: Due Diligence for Life Sciences M&A, Partnerships and Divestitures /
Philadelphia, PA
/ November 14–15: Commercial Data Insights 2018 /
Philadelphia, PA
/ November 14–15: 5th Annual Global Compliance Congress for Life Sciences /
London, UK
/ November 28–29: Compliant Patient Support Programs Summit /
Chicago, IL
/ December 4–5: Managed Markets Compliance Congress 2018 /
Philadelphia, PA
/ December 5–6: Bio/Pharma Compliance Congress on Non-Promotional Activities /
Philadelphia, PA
Business Models
Design Thinking in Pharma
When design thinking is incorporated into the business model, pharmaceutical businesses can truly differentiate themselves and recognize a valuable impact, writes Adam Taicher
/Read More/
Advertisement
Evolving Life Sciences Quality Management: Keeping Up with the New Reality
On Demand
Learn more
Audio
Pharm Exec Podcast: Midwest Biotechs and Regenerative Medicine
In this episode, Gil Van Bokkelen, CEO and co-founder of Athersys, talks about what led him and his co-founders to launch the company, the decision to set up in Ohio, and the secret to staying resilient in the c-suite even when facing extraordinary challenges
/Click here to listen/
Industry update
// Robert Bertoldi resigned from the Board of Motif Bio (New York, NY). // Rafael Pharmaceuticals (Newark, NJ) appointed Eric Van Cutsem MD, Ph.D., and Josep Tabernero, MD, Ph.D., to its Medical Advisory Board. // Orchard Therapeutics (Boston, MA, and London, UK) appointed Joanne Beck, Ph.D., to its Board of Directors. // Codexis (Redwood City, CA) appointed Hicham Alaoui, Ph.D., to the newly created position of Vice President, Biotherapeutics Research & Development. // Altimmune (Gaithersburg, MD) appointed Mitchel Sayare, Ph.D., as Executive Chairman of the Board. // Catalyst Biosciences (South San Francisco, CA) appointed Grant Blouse, Ph.D., as Vice President of Translational Research. // Clementia Pharmaceuticals (Montreal, Canada) announced the appointment of Steve Forte as Chief Financial Officer, effective August 3. Shawn Cline Tomasello also joined the company's Board of Directors. // Damien King joined the Board of Directors of Aequus Pharmaceuticals (Vancouver, Canada) to fill the seat previously held by Dr. Fotios Plakogiannis, who did not stand for re-election. //
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com